Connect with us

Business

Ontario cannabis store regulator under pressure over alleged ‘pay-to-play’ deals

Published

on

Ontario’s cannabis store regulator is facing calls to crack down on alleged pay-to-play schemes that some industry executives say allow larger marijuana producers and brands to secure shelf space for their products and other special treatment from retailers.

Industry executives say the problem ballooned earlier this year after the Alcohol and Gaming Commission of Ontario (AGCO) attempted to clarify its rules on inducements – or “slotting fees” – by issuing an update to the Registrar’s Standards for Cannabis Retail Stores – the rules governing legal marijuana stores.

Jennawae Cavion, co-founder and CEO of Calyx + Trichomes in Kingston, said pay-to-play is common in many industries, “but they’re straight up not allowed in Ontario, and I don’t understand why the AGCO and other provinces don’t do anything about it.”

“It’s a really thin veil,” she said.

To get around curbs on slotting fees, industry officials allege, some producers and brands are instead paying cannabis retailers for their sales data to ensure their products get preferential treatment in the Ontario retail market.

The monthly fee can reportedly amount to tens of thousands of dollars or more.

Some industry officials told MJBizDaily that the sales-data workaround falls into a quasi-legal gray area, given that brands and manufacturers aren’t paying directly for prime shelf or display space or exclusive sales deals involving their product.

At the same time, however, some licensed producers and retailers say many of the data-fee agreements that have become widespread are effectively slotting fees, where brands are paying to play, which is technically not allowed by Ontario’s cannabis regulator.

AGCO silent 

The cannabis store regulator in Ontario won’t say whether it has taken any specific action regarding prohibited inducement arrangements between retailers and licensed producers, even though industry sources say so-called pay-for-play deals have become rampant.

“We have received information about concerns in the sector surrounding alleged inducement activities between cannabis retailers and licensed producers,” an AGCO spokesperson said via email.

“We can confirm that we are actively monitoring and conducting regulatory activities in a number of areas related to the Standards, including inducements.”

The AGCO declined to answer MJBizDaily’s questions about the number of complaints it has received.

The regulator also wouldn’t say how many enforcement actions it has taken, if any.

The Ontario Cannabis Store, the provincial wholesaler, directed questions to the AGCO, “as this is a regulatory matter.”

In Ontario, retailers requiring or receiving payments from licensed producers for preferred shelf placement is prohibited.

Harrison Jordan, a Toronto-based lawyer who has assisted dozens of cannabis retailers, shared with MJBizDaily an emailed response from the AGCO to an inquiry about the data-sale policy:

“If the payment for the sales data is based on how much product a store stocks/sells – rather than the value of the data itself – it may not be strictly falling outside the parameters of Standard 6.6, but we would be considering whether it is a material inducement,” according to the email.

Standard 6.6 established four prohibitions “to ensure that they are not used as a method for material inducements.”

Jordan said the AGCO’s answer underscores the ambiguity surrounding the data-sale deals.

“It’s hard to ensure a level playing field when these types of arrangements aren’t definitively ruled as impermissible,” he said.

Independent entrepreneurs in Ontario, such as Paul Thompson of Little Leaf Cannabis Co. in Stratford, say it’s tough to compete fairly because the data revenue allows large corporate chains to sell marijuana below cost.

He said he’s spoken with a number of smaller LPs that are open to the “no data deal” conversation.

“There’s a movement starting, where LPs and retailers are pledging to not do data deals,” Thompson said.

“I shouldn’t have to pay you to sell weed. It just seems crazy.

“Good weed will sell itself. And I think that’s where some of these large corporations can’t compete – they just don’t have good weed.”

Can AGCO sell data?

Some entrepreneurs have told MJBizDaily that pay-to-play deals give an advantage to large companies at the expense of independently owned stores.

“(Retail chains) are using a second stream of income that’s allowing them to sell (cannabis) products at a loss,” said Mike Ainsworth, owner of Kelly’s Cannabis, an independently owned store in Huntsville.

“How is anybody expected to compete with that when they have one or two stores?”

“They’re using the millions of dollars they’re getting in data sales to subsidize their operation costs, which then allows them to sell product cheaper than any independent store in Ontario,” he said.

Ainsworth warned that such data-sale schemes could potentially force hundreds of independent stores out of business.

He wants the AGCO to enforce its rules.

“If it’s in black and white that it’s against the rules, then why was this not stopped yesterday?” he asked.

Ainsworth suggested that the AGCO could sell consumer data to producers, rather than stores selling the data themselves.

“The AGCO and OCS own all that information, so anonymize it, sell it to the LPs, and take the money,” he said.

“It levels the playing field and everybody’s happy – if it’s all about data sales and it’s not about millions of dollars falling under the table.”

Ainsworth also alleged that some brands skirted the material-inducements rule by overpaying for accessories:

“A guy will walk into your store and say, ‘How much is that bong, CA$70? Why don’t I pay you CA$7,000 for it? And there’s no way for the AGCO to audit that, and I know that has happened.”

He also said licensed producers, or agencies representing them, have bought significant amounts of gift cards and then intentionally destroyed them in front of the store owner.

Unclear rules

Michaela Freedman, an international marijuana business consultant and founder of Toronto-based MF Cannabis Consulting, said some companies are being taken advantage of because there is no transparency or standardized rules governing pay-to-play, pushing the deals into the shadows.

One retailer, whom she declined to name, was charging different slotting fees to different companies – 200 Canadian dollars ($147) per SKU versus CA$50 per SKU.

Freedman wants more clarity.

“I think it would be better relative to what we have now if they were to say these standards need to be put in place, then maybe fewer companies would be taken advantage of,” she said.

A lack of clear rules for everyone creates an uneven playing field, Freedman added.

Jordan, the Toronto-based lawyer, said he believes it’s possible to have clearer rules.

“Why even have a material-inducements policy if this stuff is going to go on regardless?” he asked. “I think the intent behind not allowing material inducements is sound.

“I do think there is a fair argument, maybe not the most friendly to mom-and-pop shops, but there is an argument that can be made to just allow them, to just regulate them, as opposed to prohibit them.”

According to Standard 6.6, agreements between retailers and LPs must not “define the amount of product from the licensed producer or its affiliates that must be offered for sale at the retail store.”

Jordan said data agreements he’s seen do not define an amount of product that must be sold or displayed.

Rather, he said, they’re simply saying, “‘If you sell 10 of our XYZ product, we’ll give you CA$5 per product that you sell, which would be in the gray area.”

“It would beg the question,” Jordan said, “Why did they go through with this rigmarole of reining material inducements in, if we’re just going to say that this kind of material inducement, which is happening, is still allowed?”

Slotting fees not sustainable

Cavion of Calyx + Trichomes said the data-sale deals aren’t sustainable.

She said some retailers are pushed into accepting data-sale arrangements because they’re desperate for cash.

“That’s what makes some of these deals tempting, is some of them are for products I would be selling anyway,” she said.

“Most kickback deals are in the 8%-10% range, and I’ve seen them as 2%-3%. The more core the product, the lower the discount that is available,” she said.

Cavion said the data deals are an advantage to large corporations, because independents have less volume.

“Big companies have an advantage because they can buy hundreds of cases and move their inventory around if they need to, but I don’t really have that ability as much,” she said.

“It doesn’t make sense for them to deal with me, an independent, because I’m such a small fish compared to a chain (of stores).

“And I have much less buying power, even though I have a busy and successful store.”

Source: https://mjbizdaily.com/ontario-cannabis-store-regulator-under-pressure-over-alleged-pay-to-play-deals/

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News